目的 探讨鲍曼不动杆菌感染的临床分布及药敏情况。 方法 对2009年1月－2011年12月的微生物送检标本进行统计分析，鲍曼不动杆菌2009年培养出19株，2010年29株（多重耐药菌株1株），2011年35株（多重耐药菌株2株），并对其分布的标本类型、科室及耐药情况进行分析。 结果 鲍曼不动杆菌在痰中检出率最高；科室分布依次为重症监护室（ICU）、神经外科、呼吸科；该菌对亚胺培南敏感性最高，对青霉素和头孢类抗生素耐药率均在55%以上。 结论 鲍曼不动杆菌感染患者的经验性抗生素治疗应根据其地区、医院最新的院内感染病原体分布及耐药性，合理选择抗生素；病情、高龄、免疫抑制剂、机械通气、多种侵入性操作及抗生素的使用为鲍曼不动杆菌医院感染危险因素；ICU存在多重耐药鲍曼不动杆菌的感染，应加以控制。
As an important tool for nucleic acid detection of variant strains of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2), the mobile air capsule construction laboratory is a key medical resource in the prevention and control of COVID-19. Medical staff, security guards, cleaners, maintenance workers and volunteers in the mobile air capsule construction laboratory have high contact frequency with the samples, so they have a high risk of infection with COVID-19. In order to reduce this risk, this article discusses the infection management measures in the aspects of wearing and taking off personal protective equipment, environmental health management, post use goods management, medical waste management, staff training management and disposal process after occupational exposure, and analyzed the common problems in operation, based on the operation process of Nanchong mobile air capsule construction laboratory. The purpose is to provide a reference for the construction and management of other mobile air capsule construction laboratory.